ArticleClinical and translational science2026
Kidney Effectiveness and Safety of Adding Spironolactone in Patients With Type 2 Diabetes Receiving Renin-Angiotensin System Inhibitors Therapy.
Wei-Ren Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.